Trial Profile
A multicenter, open-labeled, 96-week study to investigate the safety, pharmacokinetics, and efficacy of indinavir in combination with stavudine and lamivudine [lamivudine/stavudine] in pediatric patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2015
Price :
$35
*
At a glance
- Drugs Indinavir (Primary) ; Lamivudine/stavudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Oct 2005 New trial record.